Chul‐Hoon Kwon

1.3k total citations
53 papers, 925 citations indexed

About

Chul‐Hoon Kwon is a scholar working on Organic Chemistry, Molecular Biology and Rheumatology. According to data from OpenAlex, Chul‐Hoon Kwon has authored 53 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 16 papers in Molecular Biology and 14 papers in Rheumatology. Recurrent topics in Chul‐Hoon Kwon's work include Pelvic floor disorders treatments (14 papers), Anorectal Disease Treatments and Outcomes (8 papers) and Cancer therapeutics and mechanisms (6 papers). Chul‐Hoon Kwon is often cited by papers focused on Pelvic floor disorders treatments (14 papers), Anorectal Disease Treatments and Outcomes (8 papers) and Cancer therapeutics and mechanisms (6 papers). Chul‐Hoon Kwon collaborates with scholars based in United States, Taiwan and India. Chul‐Hoon Kwon's co-authors include Peter K. Sand, Roger P. Goldberg, Sanjay Gandhi, Monish Jain, Yoram Abramov, Sumana Koduri, H. Nagasawa, Frances N. Shirota, Richard F. Borch and John N.D. Wurpel and has published in prestigious journals such as Journal of Medicinal Chemistry, American Journal of Obstetrics and Gynecology and The Journal of Organic Chemistry.

In The Last Decade

Chul‐Hoon Kwon

51 papers receiving 888 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chul‐Hoon Kwon United States 17 338 327 299 216 86 53 925
William R. Turner United States 14 201 0.6× 49 0.1× 103 0.3× 269 1.2× 90 1.0× 43 822
Bernhard Olgemöller Germany 20 172 0.5× 71 0.2× 178 0.6× 562 2.6× 29 0.3× 36 1.2k
John A. Brockman United States 16 125 0.4× 45 0.1× 79 0.3× 196 0.9× 42 0.5× 34 763
Takeshi Masuda Japan 15 375 1.1× 46 0.1× 128 0.4× 239 1.1× 45 0.5× 40 862
A. Kotsis Greece 21 179 0.5× 88 0.3× 79 0.3× 310 1.4× 4 0.0× 38 1.1k
Jurij Stekar Germany 14 102 0.3× 23 0.1× 68 0.2× 400 1.9× 34 0.4× 25 1.0k
Mohamed Abdallah Egypt 10 271 0.8× 11 0.0× 73 0.2× 52 0.2× 37 0.4× 38 522
Jhansi Reddy India 17 703 2.1× 20 0.1× 45 0.2× 258 1.2× 5 0.1× 26 1.1k
Domenico Giordano Italy 16 180 0.5× 43 0.1× 123 0.4× 164 0.8× 3 0.0× 50 1.0k
Jurong Yang China 14 136 0.4× 20 0.1× 76 0.3× 381 1.8× 4 0.0× 40 984

Countries citing papers authored by Chul‐Hoon Kwon

Since Specialization
Citations

This map shows the geographic impact of Chul‐Hoon Kwon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chul‐Hoon Kwon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chul‐Hoon Kwon more than expected).

Fields of papers citing papers by Chul‐Hoon Kwon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chul‐Hoon Kwon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chul‐Hoon Kwon. The network helps show where Chul‐Hoon Kwon may publish in the future.

Co-authorship network of co-authors of Chul‐Hoon Kwon

This figure shows the co-authorship network connecting the top 25 collaborators of Chul‐Hoon Kwon. A scholar is included among the top collaborators of Chul‐Hoon Kwon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chul‐Hoon Kwon. Chul‐Hoon Kwon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Yuan‐Wan, Kuan-Yuan Chen, Chul‐Hoon Kwon, & Kun-Ming Chen. (2015). CK0403, a 9-aminoacridine, is a potent anti-cancer agent in human breast cancer cells. Molecular Medicine Reports. 13(1). 933–938. 16 indexed citations
2.
Wang, Jiang, Yi‐Jun Wang, Zhe‐Sheng Chen, & Chul‐Hoon Kwon. (2014). Synthesis and evaluation of sulfonylethyl-containing phosphotriesters of 3′-azido-3′-deoxythymidine as anticancer prodrugs. Bioorganic & Medicinal Chemistry. 22(21). 5747–5756. 5 indexed citations
3.
4.
Park, Sang-ki, et al.. (2008). Caspase-dependent cell death mediates potent cytotoxicity of sulfide derivatives of 9-anilinoacridine. Anti-Cancer Drugs. 19(4). 381–389. 13 indexed citations
5.
Liu, Mengling, et al.. (2006). Vaginal delivery and serum markers of ischemia/reperfusion injury. International Journal of Gynecology & Obstetrics. 94(2). 96–102. 12 indexed citations
6.
Goldberg, Roger P., et al.. (2005). Urinary incontinence after multiple gestation and delivery: impact on quality of life. International Urogynecology Journal. 16(5). 334–336. 16 indexed citations
7.
Abramov, Yoram, Sanjay Gandhi, Roger P. Goldberg, et al.. (2005). Site-Specific Rectocele Repair Compared With Standard Posterior Colporrhaphy. Obstetrics and Gynecology. 105(2). 314–318. 90 indexed citations
8.
Gandhi, Sanjay, Jennifer L. Beaumont, Roger P. Goldberg, et al.. (2004). Foley versus intermittent self-catheterization after transvaginal sling surgery: which works best?. Urology. 64(1). 53–57. 4 indexed citations
9.
Goldberg, Roger P., Sumana Koduri, Peter K. Sand, Chul‐Hoon Kwon, & Patrick J. Culligan. (2004). The tensile strength of Cooper?s ligament suturing: comparison of abdominal and transvaginal techniques. International Urogynecology Journal. 15(6). 425–428. 3 indexed citations
10.
Goldberg, Roger P., et al.. (2003). Prevalence of anal incontinence among mothers of multiples and analysis of risk factors. American Journal of Obstetrics and Gynecology. 189(6). 1627–1630. 19 indexed citations
11.
Goldberg, Roger P., et al.. (2003). Urinary incontinence among mothers of multiples: The protective effect of cesarean delivery. American Journal of Obstetrics and Gynecology. 188(6). 1447–1453. 36 indexed citations
12.
Kwon, Chul‐Hoon. (1999). Metabolism-based anticancer drug design. Archives of Pharmacal Research. 22(6). 533–541. 8 indexed citations
13.
Kwon, Chul‐Hoon, et al.. (1998). N3-methyl-mafosfamide as a chemically stable, alternative prodrug of mafosfamide. Bioorganic & Medicinal Chemistry Letters. 8(13). 1673–1678. 4 indexed citations
14.
Shirota, Frances N., et al.. (1995). Chemically Stable N-Methyl-4-(alkylthio)cyclophosphamide Derivatives as Prodrugs of 4-Hydroxycyclophosphamide. Journal of Medicinal Chemistry. 38(5). 848–851. 8 indexed citations
15.
Kwon, Chul‐Hoon, et al.. (1994). Structure-Activity Study of 5-Substituted 1-Carbobenzoxy-2-iminohydantoins as Potential Anticonvulsant Agents. Journal of Medicinal Chemistry. 37(18). 2841–2845. 20 indexed citations
16.
Kwon, Chul‐Hoon, et al.. (1994). In Vitro Metabolism of Aromatic Nitriles. Journal of Pharmaceutical Sciences. 83(12). 1729–1734. 12 indexed citations
17.
Nagasawa, H., Michael Lee, Chul‐Hoon Kwon, Frances N. Shirota, & Eugene G. DeMaster. (1992). An N-hydroxylated derivative of cyanamide that inhibits yeast aldehyde dehydrogenase. Alcohol. 9(5). 349–353. 16 indexed citations
18.
Kwon, Chul‐Hoon, et al.. (1992). p-(Methylsulfinyl)phenyl nitrogen mustard as a novel bioreductive prodrug selective against hypoxic tumors. Journal of Medicinal Chemistry. 35(11). 2137–2139. 14 indexed citations
19.
Kwon, Chul‐Hoon & H. Nagasawa. (1990). Intermolecular decomposition of N-acylcyanamides. The Journal of Organic Chemistry. 55(10). 3403–3406. 6 indexed citations
20.
Shirota, Frances N., H. Nagasawa, Chul‐Hoon Kwon, & Eugene G. DeMaster. (1984). N-acetylcyanamide, the major urinary metabolite of cyanamide in rat, rabbit, dog, and man.. Drug Metabolism and Disposition. 12(3). 337–344. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William R. Turner Breakdown of academic impact, for papers by Bernhard Olgemöller Breakdown of academic impact, for papers by John A. Brockman Breakdown of academic impact, for papers by Takeshi Masuda Breakdown of academic impact, for papers by A. Kotsis Breakdown of academic impact, for papers by Jurij Stekar Breakdown of academic impact, for papers by Mohamed Abdallah Breakdown of academic impact, for papers by Jhansi Reddy Breakdown of academic impact, for papers by Domenico Giordano Breakdown of academic impact, for papers by Jurong Yang
Rankless by CCL
2026